Mylan Investors

As one of the world’s leading generics and specialty pharmaceutical companies, our products reach approximately 140 countries and territories. Our leading position in key global markets is based on a broad product portfolio, robust pipeline, 20,000+ workforce, wide range of dosage forms and delivery systems, large manufacturing capacity and dedication to quality and service.

Please enable javascript to view.

MYL Last Trade

--

Change

--

Daily High

--

Daily Low

--

Daily Volume

--

Public Filings

Click here for most recent Proxy Statement  Mar 10, 2014

Click here for other Proxy Solicitation Materials  Mar 11, 2014

 

Click here for other Proxy Solicitation Materials  Mar 26, 2014



Upcoming Events

  • image

    Mylan to Present at the J.P. Morgan 33rd Annual Healthcare Conference

    San Francisco Jan 13, 2015 7:30 PM ET
    Listen to webcast

Past Events